Tenthani, Lyson; Haas, Andreas D; Tweya, Hannock; Jahn, Andreas; van Oosterhout, Joep J.; Chimbwandira, Frank; Chirwa, Zengani; Ng'ambi, Wingston; Bakali, Alan; Phiri, Sam; Myer, Landon; Valeri, Fabio; Zwahlen, Marcel; Wandeler, Gilles; Keiser, Olivia (2014). Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS, 28(4), pp. 589-98. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000143
|
Text
Tenthani AIDS 2014.pdf - Published Version Available under License Publisher holds Copyright. Download (1MB) | Preview |
OBJECTIVE
To explore the levels and determinants of loss to follow-up (LTF) under universal lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women ('Option B+') in Malawi.
DESIGN, SETTING, AND PARTICIPANTS
We examined retention in care, from the date of ART initiation up to 6 months, for women in the Option B+ program. We analysed nationwide facility-level data on women who started ART at 540 facilities (n = 21 939), as well as individual-level data on patients who started ART at 19 large facilities (n = 11 534).
RESULTS
Of the women who started ART under Option B+ (n = 21 939), 17% appeared to be lost to follow-up 6 months after ART initiation. Most losses occurred in the first 3 months of therapy. Option B+ patients who started therapy during pregnancy were five times more likely than women who started ART in WHO stage 3/4 or with a CD4 cell count 350 cells/μl or less, to never return after their initial clinic visit [odds ratio (OR) 5.0, 95% confidence interval (CI) 4.2-6.1]. Option B+ patients who started therapy while breastfeeding were twice as likely to miss their first follow-up visit (OR 2.2, 95% CI 1.8-2.8). LTF was highest in pregnant Option B+ patients who began ART at large clinics on the day they were diagnosed with HIV. LTF varied considerably between facilities, ranging from 0 to 58%.
CONCLUSION
Decreasing LTF will improve the effectiveness of the Option B+ approach. Tailored interventions, like community or family-based models of care could improve its effectiveness.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
Graduate School: |
Graduate School for Health Sciences (GHS) |
UniBE Contributor: |
Haas, Andreas, Valeri, Fabio, Zwahlen, Marcel, Wandeler, Gilles, Keiser, Olivia |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
0269-9370 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Doris Kopp Heim |
Date Deposited: |
15 Feb 2014 14:56 |
Last Modified: |
05 Dec 2022 14:28 |
Publisher DOI: |
10.1097/QAD.0000000000000143 |
PubMed ID: |
24468999 |
Additional Information: |
Tenthani, Haas and Keiser contributed equally to this work. |
Uncontrolled Keywords: |
antiretroviral therapy, loss to follow-up, option Bþ, pregnancy, prevention of mother-to-child transmission/vertical transmission retention in care |
BORIS DOI: |
10.7892/boris.41482 |
URI: |
https://boris.unibe.ch/id/eprint/41482 |